Johnson & Johnson (JNJ)
156.76
-1.42
(-0.90%)
USD |
NYSE |
Mar 18, 16:00
156.81
+0.05
(+0.03%)
After-Hours: 20:00
Johnson & Johnson Price: 156.76 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 158.57 | 158.69 | 156.50 | 156.76 | 6.543M |
Mar 15, 2024 | 158.06 | 159.19 | 157.10 | 158.18 | 13.17M |
Mar 14, 2024 | 160.94 | 161.54 | 158.69 | 159.21 | 6.988M |
Mar 13, 2024 | 162.53 | 162.68 | 159.81 | 161.10 | 6.26M |
Mar 12, 2024 | 161.58 | 163.11 | 161.13 | 162.74 | 8.019M |
Mar 11, 2024 | 159.49 | 161.32 | 158.88 | 161.23 | 4.621M |
Mar 08, 2024 | 158.87 | 160.39 | 158.42 | 159.52 | 5.284M |
Mar 07, 2024 | 160.00 | 160.36 | 158.24 | 158.87 | 5.189M |
Mar 06, 2024 | 159.46 | 160.93 | 159.22 | 159.34 | 5.774M |
Mar 05, 2024 | 160.62 | 161.24 | 159.20 | 159.97 | 8.298M |
Mar 04, 2024 | 161.32 | 161.61 | 158.27 | 159.84 | 8.533M |
Mar 01, 2024 | 161.83 | 162.57 | 161.09 | 162.12 | 5.670M |
Feb 29, 2024 | 162.00 | 162.19 | 160.94 | 161.38 | 9.849M |
Feb 28, 2024 | 161.00 | 161.61 | 160.29 | 161.55 | 6.071M |
Feb 27, 2024 | 160.34 | 161.04 | 159.64 | 160.98 | 5.079M |
Feb 26, 2024 | 161.80 | 162.01 | 160.57 | 160.79 | 5.465M |
Feb 23, 2024 | 160.88 | 162.25 | 160.16 | 161.84 | 6.726M |
Feb 22, 2024 | 158.98 | 160.74 | 157.77 | 160.45 | 8.065M |
Feb 21, 2024 | 158.02 | 158.69 | 157.13 | 158.68 | 7.473M |
Feb 20, 2024 | 156.56 | 158.61 | 156.44 | 157.86 | 9.502M |
Feb 16, 2024 | 156.60 | 157.26 | 155.67 | 156.55 | 8.541M |
Feb 15, 2024 | 155.98 | 158.48 | 155.89 | 157.92 | 7.463M |
Feb 14, 2024 | 156.35 | 156.46 | 154.84 | 155.74 | 9.099M |
Feb 13, 2024 | 157.64 | 158.45 | 155.75 | 156.47 | 8.621M |
Feb 12, 2024 | 156.58 | 158.41 | 156.35 | 157.85 | 6.702M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
111.14
Minimum
Mar 23 2020
186.01
Maximum
Apr 25 2022
156.87
Average
159.56
Median
Jan 25 2024
Price Benchmarks
Amgen Inc | 270.90 |
Gilead Sciences Inc | 73.26 |
Eli Lilly and Co | 762.66 |
Merck & Co Inc | 121.44 |
Moderna Inc | 104.26 |
Price Related Metrics
PE Ratio | 12.95 |
PS Ratio | 4.303 |
PEG Ratio | 0.1624 |
Price to Book Value | 5.491 |
Price to Free Cash Flow | 22.51 |
Earnings Yield | 7.72% |
Market Cap | 377.60B |
PEGY Ratio | 0.1566 |
Operating PE Ratio | 16.66 |
Normalized PE Ratio | 19.09 |